Complexo Hospitalario Universitario A Coruña

Care center

Foto de Complexo Hospitalario Universitario A Coruña

Foto de Carl von Ossietzky University of Oldenburg

Carl von Ossietzky University of Oldenburg

Oldenburg, Alemania

Publications in collaboration with researchers from Carl von Ossietzky University of Oldenburg (6)

2024

Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group
Clinical Microbiology and Infection

2022

Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
Clinical Lung Cancer, Vol. 23, Núm. 8, pp. 720-730

2021

Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Journal of Thoracic Oncology, Vol. 16, Núm. 12, pp. 2091-2108
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Journal of Clinical Oncology

2018

Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer
New England Journal of Medicine, Vol. 379, Núm. 21, pp. 2027-2039

CRIS project developed in collaboration with Fundación Dialnet (University of La Rioja)